CCCOC(c1ccccc1)(c1ccc(C(F)(F)F)cc1)C(Oc1nc(C)cc(C)n1)C(=O)O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?